AIM
DPLO

Alambic Investment Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Alambic Investment Management’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-24,000
Closed -$118K – 386
2019
Q3 		$118K Buy
+24,000
New +$134K 0.09% 253
2017
Q3 		– Sell
-47,400
Closed -$702K – 630
2017
Q2 		$702K Buy
+47,400
New +$790K 0.09% 328

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SI
Stephens Inc Little Rock, Arkansas $7.99B AUM 21.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
OAC
OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Alambic Investment Management's DPLO Position: Q4 2019 in Review

Alambic Investment Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2019, closing a stake of 24,000 shares — an estimated $118K sold.

Alambic Investment Management first reported a position in DPLO in Q2 2017 and held it in 2 quarters. The position peaked at $702K in Q2 2017. 138 funds tracked by Wall St. Rank hold DPLO as of Q4 2019.

  • Alambic Investment Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2019 after selling out during the quarter.
  • Alambic Investment Management sold 24,000 DIPLOMAT PHARMACY, INC. shares in Q4 2019, an estimated $118K.
  • Alambic Investment Management first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2017 and held it in 2 quarters.
  • Alambic Investment Management's DIPLOMAT PHARMACY, INC. position peaked at $702K in Q2 2017.
  • 138 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2019.

Based on Alambic Investment Management's 13F filing for Q4 2019, filed 12 Feb 2020.